A role for metallothionein in the pathogenesis of diabetes and its cardiovascular complications

Molecular Genetics and Metabolism

Volumn 94, Issue 1, 2008, Pages 1-3

  Maret, Wolfgang ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Diabetes; Metallothionein; Zinc

Indexed keywords

INSULIN; METALLOTHIONEIN 1A; METALLOTHIONEIN I; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELL PROTECTION; CELLULAR DISTRIBUTION; DIABETOGENESIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 41949140160     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.01.010     Document Type: Note

References (28)

1. Wang K., Zhou B., Kuo Y.M., Zemanski J., and Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet. 71 (2002) 66-73
2. Küry S., Dréno B., Bézieau S., Giraudet S., Kharfi M., Kamoun R., and Moisan J.P. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat. Genet. 31 (2002) 239-240
3. Chowanadisai W., Lönnerdal B., and Kelleher S.L. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J. Biol. Chem. 281 (2006) 39699-39707
4. Chimienti F., Favier A., and Seve M. ZnT-8, a pancreatic beta-cell-specific transporter. BioMetals 18 (2005) 313-317
5. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
6. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., Timpson N.J., Perry J.R.B., Rayner N.W., Freathy R.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
7. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I.W., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
8. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
9. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G.B., Styrkarsdottir U., Gretarsdottir S., Emilsson V., Gosh S., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39 (2007) 770-775
10. Staiger H., Machicao F., Stefan N., Tschritter O., Thamer C., Kantartzis K., Schäfer S.A., Kirchhoff K., Fritsche A., and Häring H.-U. Polymorphisms within novel risk loci for type 2 diabetes determine β-cell function. PLoS One 9 (2007) e832
11. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., Rewers M., Eisenbarth G.S., Jensen J., Davidson H.W., and Hutton J.C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. USA 104 (2007) 17040-17045
12. Kang S.E., Kim M.S., Kim Y.S., Kim C.H., Han S.J., Chun S.W., Hur K.Y., Nam C.M., Ahn C.W., Cha B.S., et al. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttranslational diabetes mellitus in renal allograft recipients. Diabetes (2008) 10.2337/db07-0761
13. R. Giacconi, A.R. Bonfigli, R. Testa, C. Sirolla, C. Cipriano, M. Marra, E. Muti, M. Malavolta, L. Costarelli, F. Piacenza, S. Tesei, E. Mocchegiani, Mol. Genet. Metabol., 2008, this issue., doi:10.1016/j.ymgme.2007.12.006.
14. Maret W. The function of zinc metallothionein: a link between cellular zinc and redox state. J. Nutr. 130 (2000) 1455S-1458S
15. Coulston L., and Dandona P. Insulin-like effect of zinc on adipocytes. Diabetes 29 (1980) 665-667
16. May J.R., and Contoreggi C.S. The mechanism of the insulin-like effects of ionic zinc. J. Biol. Chem. 257 (1982) 4362-4367
17. Quarterman J., Mills C.F., and Humphries W.R. The reduced secretion of, and sensitivity to insulin in zinc-deficient rats. Biochem. Biophys. Res. Commun. 25 (1966) 354-358
18. Wong V.V.T., Nissom P.M., Sim S.-L., Yeo J.H.M., Chuah S.-H., and Yap M.G.S. Zinc as an insulin replacement in hybridoma cultures. Biotech. Bioeng. 93 (2005) 553-563
19. Tang X., and Shay N.F. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J. Nutr. 131 (2001) 1414-1420
20. Haase H., and Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. BioMetals 18 (2005) 333-338
21. Wang J., Song Y., Elsherif L., Song Z., Zhou G., Prabhu S.D., Saari J.T., and Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 113 (2006) 544-554
22. Kang Y.J. The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 222 (1999) 263-273
23. Soinio M., Marniemi J., Laakso M., Pyörälä K., Lehto S., and Rönnemaa T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care 30 (2007) 523-528
24. Chausmer A.B. Zinc, insulin and diabetes. J. Am. Coll. Nutr. 17 (1998) 109-115
25. Taylor C.G. Zinc, the pancreas, and diabetes: Insights from rodent studies and future directions. BioMetals 18 (2005) 305-312
26. V. Beletate, R.P. El Dib, N. Atallah, Zinc supplementation for the prevention of type 2 diabetes mellitus (Review), Cochrane Database of Systematic Reviews 2007, Issue 1, Art. No. CD005525.
27. Schott-Ohly P., Lgssiar A., Partke H.-J., Hassan M., Friesen N., and Gleichmann H. Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-κB and AP-1 in islets, respectively. Exp. Biol. Med. 229 (2004) 1177-1185
28. Roussel A.-M., Kerkeni A., Zouari N., Mahjoub S., Matheau J.-M., and Anderson R.A. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J. Am. Coll. Nutr. 22 (2003) 316-321